Skip to main content
Premium Trial:

Request an Annual Quote

CombiMatrix and Cyrano Sciences to Co-Develop Chemical Sensors

NEW YORK, Jan. 12 (GenomeWeb News) - Acacia Research said today that its CombiMatrix microarray subsidiary will collaborate with Cyrano Sciences to develop chemical sensors that use both companies' technologies.


CombiMatrix, based in Mulkiteo, Wash., will contribute its microarray technology and Cyrano, located in Pasadena, Calif., its nanocomposite sensor or "electronic nose" technology to develop biochips for sensing chemical agents in air and water.


Up until now, CombiMatrix has developed its array technology for applications in genetic analysis, RNAi drug discovery, biodefense applications, and nanomaterials discovery.


The Scan

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.

Study Reveals Potential Sex-Specific Role for Noncoding RNA in Depression

A long, noncoding RNA called FEDORA appears to be a sex-specific regulator of major depressive disorder, affecting more women, researchers report in Science Advances.

New mRNA Vaccines Offer Hope for Fighting Malaria

A George Washington University-led team has developed mRNA vaccines for malaria that appear to provide protection in mice, as they report in NPJ Vaccines.

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.